Medspas operate in a market that has matured enough to generate reliable data, yet remains fragmented enough that benchmarking is critical. Whether you're modeling acquisition multiples, justifying capital spend on a new device, or defending your per-unit toxin pricing to a new associate, you need to know the actual market size, the growth rate, the revenue distribution, and the regulatory headwinds. This page collects the verifiable figures that inform strategy—not guesses.